Studies have shown that LY-303511 enhances the oligomerization of DR5, assembly of the DISC complex, and mitochondrial permeabilization, thereby amplifying tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in cancer cells and potentially increasing the sensitivity of chemotherapy-resistant tumors [70,71]. This evidence concerns the gene TNFRSF10B and cancer.